Parallel Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94K | Buy |
48
+8
| +20% | +$324 | ﹤0.01% | 3024 |
|
|
2025
Q1 | $2.06K | Sell |
40
-2
| -5% | -$103 | ﹤0.01% | 2956 |
|
|
2024
Q4 | $2.33K | Buy |
+42
| New | +$2.33K | ﹤0.01% | 2901 |
|
|
2023
Q4 | – | Sell |
-43
| Closed | -$764 | – | 3467 |
|
|
2023
Q3 | $764 | Hold |
43
| – | – | ﹤0.01% | 3025 |
|
|
2023
Q2 | $777 | Buy |
+43
| New | +$777 | ﹤0.01% | 2993 |
|
|
2022
Q4 | – | Sell |
-30
| Closed | -$1K | – | 3519 |
|
|
2022
Q3 | $1K | Buy |
30
+17
| +131% | +$567 | ﹤0.01% | 3001 |
|
|
2022
Q2 | $0 | Buy |
+13
| New | – | ﹤0.01% | 3347 |
|
|
2021
Q4 | – | Sell |
-44
| Closed | -$1K | – | 3298 |
|
|
2021
Q3 | $1K | Buy |
+44
| New | +$1K | ﹤0.01% | 2939 |
|